FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for metoprolol succinate from BluePoint Laboratories, enabling continued marketing of this generic beta-blocker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure
• Hypertension

Drugs mentioned

• Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

SUPPL AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)